GSK said that it was reorganizing its cooperation with CureVac, including gaining control over various vaccines they were producing together, including COVID-19 and influenza vaccines.
GlaxoSmithKline
A whistleblower has come out with allegations that GlaxoSmithKline (GSK) deceived the public about the safety of Zantac, a popular heartburn medicine.
GlaxoSmithKline pledged not to file patents to make drugs more affordable to poor countries. Any GSK drugs that are included in the list of the World Health Organization's important medicines will be included automatically.
GlaxoSmithKline (GSK.L) has taken profits in Aspen Pharmacare (APNJ.J) by selling half its stake in the South African drugmaker for $853 million, following a long investment in the firm.
Two new tools to fight AIDS should be available by 2030 in the form of a vaccine and new intense drug treatments, ending most cases of a disease that has killed millions in the past 30 years, Bill Gates said.
GlaxoSmithKline could consider more partial public share offerings for component units as it evolves in the coming years, potentially pointing to a break-up of the group if this offers value to shareholders.
GlaxoSmithKline said on Thursday it had decided not to sell a portfolio of older drugs marketed in North America and Europe after considering offers from potential buyers.
GlaxoSmithKline will this week inform U.S. staff of hundreds of job cuts in its biggest market as the drugmaker starts implementing a major cost-saving program, sources familiar with the matter said on Sunday.
Britain's biggest drugmaker, GlaxoSmithKline Plc, fired an executive from its South African unit for refusing to appear for a performance review, which was called a week after he complained of racial discrimination in the workplace, Bloomberg reported, citing company documents.
Swiss drugmaker Novartis AG (NOVN.VX) said three members of its executive committee would leave the company following the completion of transactions with GlaxoSmithKline (GSK.L) and Eli Lilly (LLY.N) to divest three units.
GlaxoSmithKline may have closed one chapter in a saga of corruption allegations by accepting a $489 million fine in China, but the drugmaker has its work cut out to win back skeptical investors.
Boston, Massachusetts-based health startup ZappRx scored a further $1 million in funding to streamline the prescription process for patients with pulmonary arterial hypertension (PAH) by becoming their electronic link to the pharmacy.
Sitari Pharmaceuticals, a San Diego, CA-based developer of multiple disease indication treatments with a focus on celiac diseases, raised USD 10 million in Series A funding. The fund would be used to continue supporting research and development of novel treatments for celiac diseases.
The following bids, mergers, acquisitions and disposals were reported on Tuesday including Nokia, IntercontinentalExchange Group, Goldman Sachs and others.
Suntory purchases two GSK drink brands for USD2 billion.
Subscribe to VCpost newsletter
Most Popular
- Nestle Cuts Sales Forecast as Shoppers Reject Price Hikes
- Social Security Payments Worth Over $4,800 To Go Out This Week; Here’s When You’ll Get Yours
- US Could See Another ‘Great Resignation’ as 3 in 10 Workers Plan To Quit in 2024: Survey
- Uber, Lyft Drivers Remain as Contractors After California Supreme Court Upheld Proposition 22
- Maersk Agrees to Settlement with US Labor Department After Firing Whistleblower
- Walmart Eyes $200 Million Investment in Autonomous Forklifts
- Delta’s CEO Flew to Paris for the Olympics While His Company Is Under Federal Investigation: Report
- Murdoch Empire Family Feud Could Upend the Media Industry, Possibly End Fox News